Skip to main content
SpringerLink
Log in

Major or Mild Vascular Neurocognitive Disorder

  • Chapter
  • First Online:
Geriatric Psychiatry

  • 2495 Accesses

Abstract

Major or mild vascular neurocognitive disorders represent the second most common cause of neurocognitive disorders. The underlying cerebrovascular disease could be multiple strokes, limited but strategic strokes, and/or significant white matter hyperintensities. The main criterion to make this diagnosis is a probable or possible causal link between cerebrovascular disease and the neurocognitive disorder. The course, neuropsychological profile, prognosis, and treatment of these disorders differ from neurodegenerative illnesses like Alzheimer disease, but can be comorbid with them. In this chapter we will provide an evidence-based review of the background of this illness and give two illustrative case examples to consolidate learning.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Arlington: American Psychiatric Association; 2013.

    Book  Google Scholar 

  2. World Health Organization. ICD-10 Version: 2015. http://apps.who.int/classifications/icd10/browse/2015/en.

  3. Hachinski VC, Lassen NA, Marshall J. Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet. 1974;2(7874):207–10.

    Article  CAS  PubMed  Google Scholar 

  4. Moroney JT, Bagiella E, Hachinski VC, Molsa PK, Gustafson L, Brun A, et al. Misclassification of dementia subtype using the Hachinski Ischemic Score: results of a meta-analysis of patients with pathologically verified dementias. Ann N Y Acad Sci. 1997;826:490–2.

    Article  CAS  PubMed  Google Scholar 

  5. Hachinski V, Oveisgharan S, Romney AK, Shankle WR. Optimizing the Hachinski Ischemic Scale. Arch Neurol. 2012;69(2):169–75.

    Article  PubMed  Google Scholar 

  6. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43(2):250–60.

    Article  CAS  PubMed  Google Scholar 

  7. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers. Neurology. 1992;42(3 Pt 1):473–80.

    Article  CAS  PubMed  Google Scholar 

  8. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. Washington, DC: American Psychiatric Associating Publishing; 1994.

    Google Scholar 

  9. Chui HC, Mack W, Jackson JE, Mungas D, Reed BR, Tinklenberg J, et al. Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability. Arch Neurol. 2000;57(2):191–6.

    Article  CAS  PubMed  Google Scholar 

  10. O’Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, et al. Vascular cognitive impairment. Lancet Neurol. 2003;2(2):89–98.

    Article  PubMed  Google Scholar 

  11. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42(9):2672–713.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Jellinger KA. The pathology of “vascular dementia”: a critical update. J Alzheimers Dis. 2008;14(1):107–23.

    Article  CAS  PubMed  Google Scholar 

  13. Hebert R, Brayne C. Epidemiology of vascular dementia. Neuroepidemiology. 1995;14(5):240–57.

    Article  CAS  PubMed  Google Scholar 

  14. Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, et al. Alzheimer’s disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol. 2008;7(9):812–26.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Jin YP, Di Legge S, Ostbye T, Feightner JW, Hachinski V. The reciprocal risks of stroke and cognitive impairment in an elderly population. Alzheimers Dement. 2006;2(3):171–8.

    Article  PubMed  Google Scholar 

  16. Barba R, Martinez-Espinosa S, Rodriguez-Garcia E, Pondal M, Vivancos J, Del Ser T. Poststroke dementia : clinical features and risk factors. Stroke. 2000;31(7):1494–501.

    Article  CAS  PubMed  Google Scholar 

  17. Pohjasvaara T, Erkinjuntti T, Vataja R, Kaste M. Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke. 1997;28(4):785–92.

    Article  CAS  PubMed  Google Scholar 

  18. Tatemichi TK, Desmond DW, Mayeux R, Paik M, Stern Y, Sano M, et al. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology. 1992;42(6):1185–93.

    Article  CAS  PubMed  Google Scholar 

  19. Lim A, Tsuang D, Kukull W, Nochlin D, Leverenz J, McCormick W, et al. Clinico-neuropathological correlation of Alzheimer’s disease in a community-based case series. J Am Geriatr Soc. 1999;47(5):564–9.

    Article  CAS  PubMed  Google Scholar 

  20. Neuropathology Group. Medical Research Council Cognitive F, Aging S. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet. 2001;357(9251):169–75.

    Article  Google Scholar 

  21. White L, Petrovitch H, Hardman J, Nelson J, Davis DG, Ross GW, et al. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci. 2002;977:9–23.

    Article  PubMed  Google Scholar 

  22. Barker WW, Luis CA, Kashuba A, Luis M, Harwood DG, Loewenstein D, et al. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord. 2002;16(4):203–12.

    Article  PubMed  Google Scholar 

  23. Knopman DS, Parisi JE, Boeve BF, Cha RH, Apaydin H, Salviati A, et al. Vascular dementia in a population-based autopsy study. Arch Neurol. 2003;60(4):569–75.

    Article  PubMed  Google Scholar 

  24. Fernando MS, Ince PG, Function MRCC. Ageing Neuropathology Study G. Vascular pathologies and cognition in a population-based cohort of elderly people. J Neurol Sci. 2004;226(1–2):13–7.

    Article  PubMed  Google Scholar 

  25. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006;37(9):2220–41.

    Article  PubMed  Google Scholar 

  26. Black S, Gao F, Bilbao J. Understanding white matter disease: imaging-pathological correlations in vascular cognitive impairment. Stroke. 2009;40(3 Suppl):S48–52.

    Article  PubMed  Google Scholar 

  27. Kalaria RN. Risk factors and neurodegenerative mechanisms in stroke related dementia. Panminerva Med. 2012;54(3):139–48.

    CAS  PubMed  Google Scholar 

  28. Yip AG, McKee AC, Green RC, Wells J, Young H, Cupples LA, et al. APOE, vascular pathology, and the AD brain. Neurology. 2005;65(2):259–65.

    Article  CAS  PubMed  Google Scholar 

  29. Esiri MM, Wilcock GK, Morris JH. Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry. 1997;63(6):749–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Esiri MM. Which vascular lesions are of importance in vascular dementia? Ann N Y Acad Sci. 2000;903:239–43.

    Article  CAS  PubMed  Google Scholar 

  31. Pantoni L, Garcia JH. Cognitive impairment and cellular/vascular changes in the cerebral white matter. Ann N Y Acad Sci. 1997;826:92–102.

    Article  CAS  PubMed  Google Scholar 

  32. Markus H. Risk of stroke in asymptomatic carotid stenosis. Lancet. 1995;345(8951):721.

    Article  CAS  PubMed  Google Scholar 

  33. Sahlas DJ, Bilbao JM, Swartz RH, Black SE. Clasmatodendrosis correlating with periventricular hyperintensity in mixed dementia. Ann Neurol. 2002;52(3):378–81.

    Article  PubMed  Google Scholar 

  34. Simpson JE, Fernando MS, Clark L, Ince PG, Matthews F, Forster G, et al. White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses. Neuropathol Appl Neurobiol. 2007;33(4):410–9.

    Article  CAS  PubMed  Google Scholar 

  35. Mandybur TI. Cerebral amyloid angiopathy: the vascular pathology and complications. J Neuropathol Exp Neurol. 1986;45(1):79–90.

    Article  CAS  PubMed  Google Scholar 

  36. Natte R, Vinters HV, Maat-Schieman ML, Bornebroek M, Haan J, Roos RA, et al. Microvasculopathy is associated with the number of cerebrovascular lesions in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Stroke. 1998;29(8):1588–94.

    Article  CAS  PubMed  Google Scholar 

  37. Vonsattel JP, Myers RH, Hedley-Whyte ET, Ropper AH, Bird ED, Richardson EP Jr. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol. 1991;30(5):637–49.

    Article  CAS  PubMed  Google Scholar 

  38. Jellinger KA. Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm (Vienna). 2002;109(5–6):813–36.

    Article  CAS  Google Scholar 

  39. Arvanitakis Z, Leurgans SE, Wang Z, Wilson RS, Bennett DA, Schneider JA. Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol. 2011;69(2):320–7.

    Article  PubMed  Google Scholar 

  40. O’Rourke MF, Nichols WW. Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension. Hypertension. 2005;45(4):652–8.

    Article  PubMed  Google Scholar 

  41. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27(21):2588–605.

    Article  PubMed  Google Scholar 

  42. Laurent S, Boutouyrie P. Recent advances in arterial stiffness and wave reflection in human hypertension. Hypertension. 2007;49(6):1202–6.

    Article  CAS  PubMed  Google Scholar 

  43. Laurent S, Boutouyrie P, Lacolley P. Structural and genetic bases of arterial stiffness. Hypertension. 2005;45(6):1050–5.

    Article  CAS  PubMed  Google Scholar 

  44. Elias MF, Robbins MA, Budge MM, Abhayaratna WP, Dore GA, Elias PK. Arterial pulse wave velocity and cognition with advancing age. Hypertension. 2009;53(4):668–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Scuteri A, Brancati AM, Gianni W, Assisi A, Volpe M. Arterial stiffness is an independent risk factor for cognitive impairment in the elderly: a pilot study. J Hypertens. 2005;23(6):1211–6.

    Article  CAS  PubMed  Google Scholar 

  46. Scuteri A, Tesauro M, Appolloni S, Preziosi F, Brancati AM, Volpe M. Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual. J Hypertens. 2007;25(5):1035–40.

    Article  CAS  PubMed  Google Scholar 

  47. Hanon O, Haulon S, Lenoir H, Seux ML, Rigaud AS, Safar M, et al. Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory loss. Stroke. 2005;36(10):2193–7.

    Article  PubMed  Google Scholar 

  48. Waldstein SR, Rice SC, Thayer JF, Najjar SS, Scuteri A, Zonderman AB. Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. Hypertension. 2008;51(1):99–104.

    Article  CAS  PubMed  Google Scholar 

  49. Morovic S, Jurasic MJ, Martinic Popovic I, Seric V, Lisak M, Demarin V. Vascular characteristics of patients with dementia. J Neurol Sci. 2009;283(1–2):41–3.

    Article  PubMed  Google Scholar 

  50. van Beek AH, Claassen JA, Rikkert MG, Jansen RW. Cerebral autoregulation: an overview of current concepts and methodology with special focus on the elderly. J Cereb Blood Flow Metab. 2008;28(6):1071–85.

    Article  PubMed  Google Scholar 

  51. Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron. 2008;57(2):178–201.

    Article  CAS  PubMed  Google Scholar 

  52. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer’s disease. Nat Rev Neurosci. 2004;5(5):347–60.

    Article  CAS  PubMed  Google Scholar 

  53. Iadecola C, Davisson RL. Hypertension and cerebrovascular dysfunction. Cell Metab. 2008;7(6):476–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Iadecola C, Park L, Capone C. Threats to the mind: aging, amyloid, and hypertension. Stroke. 2009;40(3 Suppl):S40–4.

    Article  PubMed  Google Scholar 

  55. Zacchigna S, Lambrechts D, Carmeliet P. Neurovascular signalling defects in neurodegeneration. Nat Rev Neurosci. 2008;9(3):169–81.

    Article  CAS  PubMed  Google Scholar 

  56. Sadowski M, Pankiewicz J, Scholtzova H, Li YS, Quartermain D, Duff K, et al. Links between the pathology of Alzheimer’s disease and vascular dementia. Neurochem Res. 2004;29(6):1257–66.

    Article  CAS  PubMed  Google Scholar 

  57. Dichgans M. Genetics of ischaemic stroke. Lancet Neurol. 2007;6(2):149–61.

    Article  CAS  PubMed  Google Scholar 

  58. Obeid R, Herrmann W. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett. 2006;580(13):2994–3005.

    Article  CAS  PubMed  Google Scholar 

  59. Quadri P, Fragiacomo C, Pezzati R, Zanda E, Forloni G, Tettamanti M, et al. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr. 2004;80(1):114–22.

    CAS  PubMed  Google Scholar 

  60. Perry EK, Gibson PH, Blessed G, Perry RH, Tomlinson BE. Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J Neurol Sci. 1977;34(2):247–65.

    Article  CAS  PubMed  Google Scholar 

  61. Roman GC, Kalaria RN. Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia. Neurobiol Aging. 2006;27(12):1769–85.

    Article  CAS  PubMed  Google Scholar 

  62. White L, Small BJ, Petrovitch H, Ross GW, Masaki K, Abbott RD, et al. Recent clinical-pathologic research on the causes of dementia in late life: update from the Honolulu-Asia Aging Study. J Geriatr Psychiatry Neurol. 2005;18(4):224–7.

    Article  PubMed  Google Scholar 

  63. Schneider JA, Aggarwal NT, Barnes L, Boyle P, Bennett DA. The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimers Dis. 2009;18(3):691–701.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Sonnen JA, Larson EB, Crane PK, Haneuse S, Li G, Schellenberg GD, et al. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol. 2007;62(4):406–13.

    Article  PubMed  Google Scholar 

  65. Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69(24):2197–204.

    Article  PubMed  Google Scholar 

  66. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA. 1997;277(10):813–7.

    Article  CAS  PubMed  Google Scholar 

  67. Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology. 2004;62(7):1148–55.

    Article  CAS  PubMed  Google Scholar 

  68. Nagy Z, Esiri MM, Jobst KA, Morris JH, King EM, McDonald B, et al. The effects of additional pathology on the cognitive deficit in Alzheimer disease. J Neuropathol Exp Neurol. 1997;56(2):165–70.

    Article  CAS  PubMed  Google Scholar 

  69. Khan A, Kalaria RN, Corbett A, Ballard C. Update on Vascular Dementia. J Geriatr Psychiatry Neurol. 2016;29(5):281–301.

    Article  PubMed  Google Scholar 

  70. Roman GC. Vascular dementia may be the most common form of dementia in the elderly. J Neurol Sci. 2002;203–204:7–10.

    Article  PubMed  Google Scholar 

  71. Bruandet A, Richard F, Bombois S, Maurage CA, Deramecourt V, Lebert F, et al. Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease. J Neurol Neurosurg Psychiatry. 2009;80(2):133–9.

    Article  CAS  PubMed  Google Scholar 

  72. Srikanth S, Nagaraja AV, Ratnavalli E. Neuropsychiatric symptoms in dementia-frequency, relationship to dementia severity and comparison in Alzheimer’s disease, vascular dementia and frontotemporal dementia. J Neurol Sci. 2005;236(1–2):43–8.

    Article  CAS  PubMed  Google Scholar 

  73. Staekenborg SS, Su T, van Straaten EC, Lane R, Scheltens P, Barkhof F, et al. Behavioural and psychological symptoms in vascular dementia; differences between small- and large-vessel disease. J Neurol Neurosurg Psychiatry. 2010;81(5):547–51.

    Article  PubMed  Google Scholar 

  74. Ballard C, Neill D, O’Brien J, McKeith IG, Ince P, Perry R. Anxiety, depression and psychosis in vascular dementia: prevalence and associations. J Affect Disord. 2000;59(2):97–106.

    Article  CAS  PubMed  Google Scholar 

  75. Chiu PY, Liu CH, Tsai CH. Neuropsychiatric manifestations in vascular cognitive impairment patients with and without dementia. Acta Neurol Taiwanica. 2007;16(2):86–91.

    Google Scholar 

  76. Fuh JL, Wang SJ, Cummings JL. Neuropsychiatric profiles in patients with Alzheimer’s disease and vascular dementia. J Neurol Neurosurg Psychiatry. 2005;76(10):1337–41.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000;12(2):233–9.

    Article  CAS  PubMed  Google Scholar 

  78. Parikh RM, Eden DT, Price TR, Robinson RG. The sensitivity and specificity of the Center for Epidemiologic Studies Depression Scale in screening for post-stroke depression. Int J Psychiatry Med. 1988;18(2):169–81.

    Article  CAS  PubMed  Google Scholar 

  79. Agrell B, Dehlin O. Comparison of six depression rating scales in geriatric stroke patients. Stroke. 1989;20(9):1190–4.

    Article  CAS  PubMed  Google Scholar 

  80. Critchley M. Atherosclerotic parkinsonism. Brain. 1929;52:23–83.

    Article  Google Scholar 

  81. Thompson PD, Marsden CD. Gait disorder of subcortical arteriosclerotic encephalopathy: Binswanger’s disease. Mov Disord. 1987;2(1):1–8.

    Article  CAS  PubMed  Google Scholar 

  82. FitzGerald PM, Jankovic J. Lower body parkinsonism: evidence for vascular etiology. Mov Disord. 1989;4(3):249–60.

    Article  CAS  PubMed  Google Scholar 

  83. Chang CM, Yu YL, Ng HK, Leung SY, Fong KY. Vascular pseudoparkinsonism. Acta Neurol Scand. 1992;86(6):588–92.

    Article  CAS  PubMed  Google Scholar 

  84. Meyer JS, Barron DW. Apraxia of Gait: a clinicophysiological study. Brain. 1960;83:261–84.

    Article  Google Scholar 

  85. Carboncini MC, Volterrani D, Bonfiglio L, Barsotti G, Della Porta M, Mariani G, et al. Higher level gait disorders in subcortical chronic vascular encephalopathy: a single photon emission computed tomography study. Age Ageing. 2009;38(3):302–7.

    Article  PubMed  Google Scholar 

  86. Juva K, Makela M, Erkinjuntti T, Sulkava R, Ylikoski R, Valvanne J, et al. Functional assessment scales in detecting dementia. Age Ageing. 1997;26(5):393–400.

    Article  CAS  PubMed  Google Scholar 

  87. Hershey LA, Jaffe DF, Greenough PG, Yang SL. Validation of cognitive and functional assessment instruments in vascular dementia. Int J Psychiatry Med. 1987;17(2):183–92.

    Article  CAS  PubMed  Google Scholar 

  88. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.

    Article  PubMed  Google Scholar 

  89. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239–59.

    Article  CAS  PubMed  Google Scholar 

  90. Tulving E, Craik FIM. The Oxford handbook of memory, vol. xiv. Oxford, New York: Oxford University Press; 2000. p. 700.

    Google Scholar 

  91. Yamamoto Y, Ihara M, Tham C, Low RW, Slade JY, Moss T, et al. Neuropathological correlates of temporal pole white matter hyperintensities in CADASIL. Stroke. 2009;40(6):2004–11.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Fisher CM. Capsular infarcts: the underlying vascular lesions. Arch Neurol. 1979;36(2):65–73.

    Article  CAS  PubMed  Google Scholar 

  93. de Jong G, Kessels F, Lodder J. Two types of lacunar infarcts: further arguments from a study on prognosis. Stroke. 2002;33(8):2072–6.

    Article  PubMed  Google Scholar 

  94. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–38.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Longstreth WT Jr, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke. 1996;27(8):1274–82.

    Article  PubMed  Google Scholar 

  96. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348(13):1215–22.

    Article  PubMed  Google Scholar 

  97. Hachinski VC, Potter P, Merskey H. Leuko-araiosis. Arch Neurol. 1987;44(1):21–3.

    Article  CAS  PubMed  Google Scholar 

  98. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjogren M, et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 2001;32(6):1318–22.

    Article  CAS  PubMed  Google Scholar 

  99. Wen W, Sachdev PS, Li JJ, Chen X, Anstey KJ. White matter hyperintensities in the forties: their prevalence and topography in an epidemiological sample aged 44–48. Hum Brain Mapp. 2009;30(4):1155–67.

    Article  PubMed  Google Scholar 

  100. Kapeller P, Barber R, Vermeulen RJ, Ader H, Scheltens P, Freidl W, et al. Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements. Stroke. 2003;34(2):441–5.

    Article  CAS  PubMed  Google Scholar 

  101. Anbeek P, Vincken KL, van Osch MJ, Bisschops RH, van der Grond J. Probabilistic segmentation of white matter lesions in MR imaging. NeuroImage. 2004;21(3):1037–44.

    Article  PubMed  Google Scholar 

  102. Firbank MJ, He J, Blamire AM, Singh B, Danson P, Kalaria RN, et al. Cerebral blood flow by arterial spin labeling in poststroke dementia. Neurology. 2011;76(17):1478–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Viswanathan A, Chabriat H. Cerebral microhemorrhage. Stroke. 2006;37(2):550–5.

    Article  PubMed  Google Scholar 

  104. Roob G, Fazekas F. Magnetic resonance imaging of cerebral microbleeds. Curr Opin Neurol. 2000;13(1):69–73.

    Article  CAS  PubMed  Google Scholar 

  105. Schrag M, McAuley G, Pomakian J, Jiffry A, Tung S, Mueller C, et al. Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study. Acta Neuropathol. 2010;119(3):291–302.

    Article  PubMed  PubMed Central  Google Scholar 

  106. Ayaz M, Boikov AS, Haacke EM, Kido DK, Kirsch WM. Imaging cerebral microbleeds using susceptibility weighted imaging: one step toward detecting vascular dementia. J Magn Reson Imaging. 2010;31(1):142–8.

    Article  PubMed  PubMed Central  Google Scholar 

  107. Dziewulska D. Mysteries of CADASIL—the contribution of neuropathology to understanding of the disease. Folia Neuropathol. 2009;47(1):1–10.

    CAS  PubMed  Google Scholar 

  108. Goto Y. Clinical application of molecular diagnosis for mitochondrial encephalomyopathies. Hokkaido Igaky Zasshi. 1992;67(1):27–39.

    CAS  Google Scholar 

  109. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996;46(4):907–11.

    Article  CAS  PubMed  Google Scholar 

  110. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50(1):121–7.

    Article  CAS  PubMed  Google Scholar 

  111. Brodaty H, Clarke J, Ganguli M, Grek A, Jorm AF, Khachaturian Z, et al. Screening for cognitive impairment in general practice: toward a consensus. Alzheimer Dis Assoc Disord. 1998;12(1):1–13.

    Article  CAS  PubMed  Google Scholar 

  112. Pantoni L, Rossi R, Inzitari D, Bianchi C, Beneke M, Erkinjuntti T, et al. Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial. J Neurol Sci. 2000;175(2):124–34.

    Article  CAS  PubMed  Google Scholar 

  113. Wang S, Yang H, Zhang J, Zhang B, Liu T, Gan L, et al. Efficacy and safety assessment of acupuncture and nimodipine to treat mild cognitive impairment after cerebral infarction: a randomized controlled trial. BMC Complement Altern Med. 2016;16:361.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  114. Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142–8.

    Article  CAS  PubMed  Google Scholar 

  115. Geschwind MD, Shu H, Haman A, Sejvar JJ, Miller BL. Rapidly progressive dementia. Ann Neurol. 2008;64(1):97–108.

    Article  PubMed  PubMed Central  Google Scholar 

  116. Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139(9):1136–9.

    Article  CAS  PubMed  Google Scholar 

  117. PeBenito R. Developmental Gerstmann syndrome: case report and review of the literature. J Dev Behav Pediatr. 1987;8(4):229–32.

    Article  CAS  PubMed  Google Scholar 

  118. Chen Y, Patel NC, Guo JJ, Zhan S. Antidepressant prophylaxis for poststroke depression: a meta-analysis. Int Clin Psychopharmacol. 2007;22(3):159–66.

    Article  PubMed  Google Scholar 

  119. Jorge RE, Acion L, Moser D, Adams HP Jr, Robinson RG. Escitalopram and enhancement of cognitive recovery following stroke. Arch Gen Psychiatry. 2010;67(2):187–96.

    Article  PubMed  PubMed Central  Google Scholar 

  120. Mead GE, Hsieh CF, Hackett M. Selective serotonin reuptake inhibitors for stroke recovery. JAMA. 2013;310(10):1066–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Parkwood Institute-Mental Health/Western University, London, ON, Canada

    Amer M. Burhan MBChB, MSc

  2. Parkwood Institute-Mental Health, London, ON, Canada

    Manoosh Moradizadeh

  3. St. Joseph’s Health Care London, Parkwood Institute, London, ON, Canada

    Nicole E. Marlatt

Authors
  1. Amer M. Burhan MBChB, MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manoosh Moradizadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nicole E. Marlatt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amer M. Burhan MBChB, MSc .

Editor information

Editors and Affiliations

  1. Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada

    Ana Hategan

  2. Baylor Scott and White Department of Psychiatry, Texas A&M University College of Medicine, Temple, Texas, USA

    James A. Bourgeois

  3. Division of General Medicine, University of California Davis Medical Center, Sacramento, California, USA

    Calvin H. Hirsch

  4. Department of Psychiatry and Behavioral Sciences, University of California Davis Medical Center, Sacramento, California, USA

    Caroline Giroux

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Burhan, A.M., Moradizadeh, M., Marlatt, N.E. (2018). Major or Mild Vascular Neurocognitive Disorder. In: Hategan, A., Bourgeois, J., Hirsch, C., Giroux, C. (eds) Geriatric Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-319-67555-8_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-67555-8_21

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-67554-1

  • Online ISBN: 978-3-319-67555-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation